Table 1 Baseline characteristics and outcomes for all patients and according to insulin therapy during the first 24 h in ICU
From: The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
Characteristic | All patients (n = 45) | Non-insulin group (n = 25) | Insulin group (n = 20) | P |
|---|---|---|---|---|
Age (years) | 68 (61, 77) | 69 (60, 78) | 67 (64, 73) | 0.53 |
Female sex, n (%) | 20 (44.4%) | 14 (56%) | 6 (30%) | 0.08 |
APACHE III score | 64 (43, 76) | 65 (48, 86) | 64 (42, 72) | 0.42 |
HbA1c (%) | 6.7 (6.2, 7.3) | 6.4 (5.9, 6.9) | 7.1 (6.3, 7.8) | 0.02 |
Body weight (kg) | 80 (72, 93) | 75 (71, 85) | 87 (73, 97) | 0.14 |
Chronic insulin therapy, n (%) | 12 (26.7%) | 4 (16.0%) | 8 (40.0%) | 0.07 |
Source of ICU admission, n (%) | ||||
Operating theater | 20 (44.4%) | 9 (36%) | 11 (55%) | 0.55 |
Emergency Department | 7 (15.6%) | 5 (20%) | 2 (10%) | |
Ward | 11 (24.4%) | 6 (24%) | 5 (25%) | |
Other hospital | 7 (15.6%) | 5 (20%) | 2 (10%) | |
Vasopressor therapy on admission, n (%) | 15 (33.3%) | 6 (24%) | 9 (45%) | 0.14 |
Mechanical ventilation on admission, n (%) | 21 (46.7%) | 10 (40%) | 11 (55%) | 0.32 |
ICU length of stay (days) | 2.6 (1.7, 3.9) | 2.6 (1.8, 3.9) | 2.7 (1.4, 4.6) | 1.0 |
Hospital length of stay (days) | 10 (6.8, 15.0) | 9.6 (4.9, 15.0) | 11 (8.0, 18.0) | 0.27 |
ICU mortality, n (%) | 4 (8.9%) | 4 (16%) | 0 | – |
Hospital mortality, n (%) | 4 (8.9%) | 4 (16%) | 0 | – |